Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

• Extended Release Tacrolimus Formulations: Pharmacokinetics and Clinical Use in Renal Transplantation


The goal of this program is to compare and contrast the two oral extended release tacrolimus formulations currently approved by the United States Food and Drug Administration (FDA) for use in renal transplantation, and discuss the unique pharmacokinetics of the two oral extended release tacrolimus formulations currently approved by the United States Food and Drug Administration (FDA) for use in renal transplantation compared to immediate release tacrolimus formulations.
 
This program includes a one hour video and downloadable copies of the presentation slides in PDF. 
 
This program was produced through a cosponosor partnership with the American College of Clincial Pharmacy (ACCP) Immunology Transplantation PRN division.

Fee

$25.00

CE Hours

1.00

CE Units

0.100

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
 

Co-Sponsor(s)

ACCP Immunology Transplantation PRN

Requirements for CE Credit

The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This online activity is approved for 0.10 CEUs (1.00 contact hours) of continuing education credit.  In order to receive 1.00 contact hours of CE credit, the participant must watch the video in its entirety, complete the online post-test, and complete the online evaluation. 

 

 

 

Objectives

  • Compare and contrast the two oral extended release tacrolimus formulations currently approved by the United States Food and Drug Administration (FDA) for use in renal transplantation
  • Describe the unique pharmacokinetics of the two oral extended release tacrolimus formulations currently approved by the United States Food and Drug Administration (FDA) for use in renal transplantation
  • Compared extended release tacrolimus to immediate release tacrolimus formulations

Speaker(s)/Author(s)

Jennifer Trofe-Clark, Pharm D, FCCP, FAST, BCPS
University of Pennsylvaia


Brief Bio : Jennifer Trofe-Clark, Pharm D, FCCP, BCPS, FAST, has been a practicing clinical transplant pharmacist for the past 11 years at the Hospital of the University of Pennsylvania, with a focus on renal, pancreas and vascular composite allotransplantation. In her current position, she works in all phases of transplant care, and actively participates in clinical research in these areas with an emphasis on immunosuppressive trials.

Activity Number

0067-9999-16-083-H01-P

Release Date: Sep 27, 2016
Credit Expiration Date: Sep 25, 2019

CE Hours

1.00